Chloromethane

Chloromethane

SCHEMBL631142

C=CC(=O)OCC[N+](C)(C)C.CCl

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.52
CHRM5 P08912 6/20 0.52
CHRM1 P11229 6/20 0.52
CHRM3 P20309 6/20 0.52
CHRM2 P08172 5/20 0.52
CHRM4 P08173 5/20 0.52
CHRNB2 P17787 4/20 0.52
CHRNA4 P43681 4/20 0.52
ALDH1A1 P00352 3/20 0.52
CHRNA7 P36544 3/20 0.52
TP53 P04637 2/20 0.52
HIF1A Q16665 2/20 0.52
HTR1A P08908 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
ADRA2A P08913 1/20 0.52
ADRA1A P35348 1/20 0.52
CYP3A4 P08684 1/20 0.52
PGR P06401 1/20 0.52
TBXA2R P21731 1/20 0.52
CHRNB4 P30926 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20908 0.96 TSHR (0.56) TSHRCHRM5CHRM1CHRM3CHRM2
SCHEMBL25422044 0.96 TSHR (0.56) TSHRCHRM5CHRM1CHRM3CHRM2
SCHEMBL1703727 0.94 TSHR (0.54) TSHRCHRM5CHRM1CHRM3CHRM2
Hydrochloric Acid SCHEMBL28367647 0.94 TSHR (0.54) TSHRCHRM5CHRM1CHRM3CHRM2
Water SCHEMBL4899700 0.94 TSHR (0.54) TSHRCHRM5CHRM1CHRM3CHRM2
Bromide SCHEMBL1254964 0.94 GALR3 (0.57) TSHRCHRM5CHRM1CHRM3CHRM2
Hydrochloric Acid SCHEMBL15738807 0.94 TSHR (0.54) TSHRCHRM5CHRM1CHRM3CHRM2
Hydrochloric Acid SCHEMBL134541 0.94 CHRM5 (0.57) TSHRCHRM5CHRM1CHRM3CHRM2
Fluoride Ion SCHEMBL1254299 0.94 TSHR (0.54) TSHRCHRM5CHRM1CHRM3CHRM2
Iodide SCHEMBL1254880 0.94 TSHR (0.54) TSHRCHRM5CHRM1CHRM3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107051481-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-08-18 CN claimed
CN-107051521-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-08-18 CN claimed
CN-107051441-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-08-18 CN claimed
CN-107051485-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-08-18 CN claimed
CN-107051480-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-08-18 CN claimed
CN-107029744-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-08-11 CN claimed
CN-107020129-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-08-08 CN claimed
CN-107008273-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-08-04 CN claimed
CN-107008359-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-08-04 CN claimed
CN-107008351-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-08-04 CN claimed
CN-107008280-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-08-04 CN claimed
CN-107008391-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-08-04 CN claimed
CN-106984347-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-07-28 CN claimed
CN-102106789-B Comprise the cosmetic composition of at least two volatile linear alkane and at least one non-protein cationic polymer 欧莱雅 2016-08-10 CN claimed
CN-103298535-B Flocculation agents for nanoparticle pollutants EMPIRE TECHNOLOGY DEV LLC 2015-01-28 CN claimed
CN-109199898-A Composition and its application method containing oxidant 朋友株式会社 2019-01-15 CN disclosed
CN-109199892-A Composition and its application method containing oxidant 朋友株式会社 2019-01-15 CN disclosed
US-20050124724-A1 Polymer compositions with bioactive agent, medical articles, and methods 3M INNOVATIVE PROPERTIES COMPANY 2005-06-09 US disclosed
WO-2004080499-A1 POLYMER COMPOSITIONS WITH BIOACTIVE SILVER, COPPER OR ZINC COMPOUNDS, MEDICAL ARTICLES, AND PROCESSES 3M INNOVATIVE PROPERTIES COMPANY (US) 2004-09-23 WO disclosed
US-20040180093-A1 Polymer compositions with bioactive agent, medical articles, and methods 3M INNOVATIVE PROPERTIES COMPANY 2004-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180093-A1 Polymer compositions with bioactive agent, medical articles, and methods ZRANB2, PUF60, BMP2 TSHR 4202/4885CHRM5 4475/4885CHRM1 4487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.